PCSK1 and lipodystrophy: Interestingly, preventing necroptosis using NEC-1 also improves the lipodystrophy phenotype and comorbidities; however, inhibition of necroptosis will presumably not resolve the cellular ROS stress induced by MED20 deficiency.